“World in motion” – emulsion adjuvants rising to meet the pandemic challenges

Emulsion adjuvants such as MF59 and AS03 have been used for more than two decades as key components of licensed vaccines, with over 100 million doses administered to diverse populations in more than 30 countries. Substantial clinical experience of effectiveness and a well-established safety profile,...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Hagan, Derek T., van der Most, Robbert, Lodaya, Rushit N., Coccia, Margherita, Lofano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692316/
https://www.ncbi.nlm.nih.gov/pubmed/34934069
http://dx.doi.org/10.1038/s41541-021-00418-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692316/
https://www.ncbi.nlm.nih.gov/pubmed/34934069
http://dx.doi.org/10.1038/s41541-021-00418-0

Ejemplares similares